Clinical Trials
- Chronic Electrical Stimulation of the Auditory Cortex for Intractable Tinnitus
- Cognitive Behavioral Therapy for Hyperacusis
- Customized Acoustic Stimulation for Long Term Medical Benefit for the Relief of Tinnitus and Hyperacusis
- Evaluation of the Elimination of Tinnitus and Hyperacusis by the ØREBLUE® Method
- Exploratory Study on the Role of Somatic Modulation in Hyperacusis
- Exposure Therapy for Auditory Sensitivity in Autism
- Intervention for Reduced Sound Tolerance
- Role of Exposure in Hyperacusis
- Treatment of Tinnitus With Noninvasive Neuromodulation and Listening Therapy
- Adrenal Venous Sampling Via an Antecubital Approach
- Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
- Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
- Establishment of Aldosterone and Renin Reference Range
- Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction
- Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism
- Acupuncture or Metformin for Insulin Resistance in Women With PCOS
- Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- Adrenal Hyperplasia Among Young People With PCOS
- Assessment of Day-night Secretion of Progesterone and LH Across Puberty
- Bariatric Surgery, Hormones, and Quality of Life
- Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome
- Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women
- Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism
- Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women
- Effect of Free Fatty Acids (FFA) on Androgen Precursors in Women
- Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
- Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
- Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
- Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
- Effects of Androgen Administration on Inflammation in Normal Women
- Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
- Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation
- Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
- Inositol Supplementation to Treat PCOS (INSUPP-PCOS)
- Lactobacillus Rhamnosus and PCOS Treatment
- Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome
- Mechanisms of Blood Pressure Dysfunction in Transmen Receiving Testosterone
- Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic Females
- Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
- Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study
- Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
- Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
- Phlebotomy and Polycystic Ovary Syndrome
- Presentations of Hyperandrogenic Phenotypes in Taiwanese Women
- Sleep-wake Changes of Luteinizing Hormone Frequency in Pubertal Girls With and Without High Testosterone
- Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone
- The Effect of Ibuprofen on Women With PCOS.
- The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women
- Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome
- Ultrasound Three-dimensional Characterization of Ovarian Morphology in Women With Polycystic Ovary Syndrome (PCOS)
- Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
- Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome
- A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome
- A Study of AKCEA-APOCIII-LRx Administered to Patients With Familial Chylomicronemia Syndrome (FCS)
- A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen
- A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)
- Glybera Registry, Lipoprotein Lipase Deficient (LPLD) Patients
- InFocus France Epidemiological Study of Health Burden in Major Hypertriglyceridemia
- Medical Complications in Familial and Multifactorial Chylomicronaemia Syndromes
- Phase 2 Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Familial Chylomicronemia Syndrome (FCS)
- Study of ARO-APOC3 in Adults With Familial Chylomicronemia Syndrome (FCS)
- Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)
- The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
- The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
- Volanesorsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS)
- An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
- Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)
- Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)
- FH Detection in Children by Salivary Test
- Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
- Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia
- Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
- Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)
- Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia
- Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
- Type III Dysbetalipoproteinemia
- A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
- A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
- A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis
- A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
- A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis
- A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
- A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505 to Treat Hyperphosphatemia in Hemodialysis Patients
- A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
- A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis
- A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
- A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
- A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia
- A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia
- A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
- A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
- A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
- A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD
- A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease
- A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
- A Study of Ferric Citrate to Improve Inflammation and Lipid Levels
- A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
- A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
- A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
- A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis
- A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients
- A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia
- An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
- An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease
- An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis
- An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
- Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate
- Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
- Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants
- BAY 77-1931 Long-term Extension From Phase II Study
- Behavioral Management of Phosphorus in Hemodialysis Patients
- Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers
- Bioequivalence Study of BAY77-1931 Granule
- Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients
- Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis
- Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices
- Dose Finding Study to Treat High Phosphate Levels in the Blood.
- Dose-finding Study of KHK7791 in Hyperphosphatemia Patients
- Dose-finding Study of MCI-196
- Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia
- Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects
- DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis
- Effect of Restriction of Foods Containing Phosphorus Additives
- Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)
- Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients
- Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia
- Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients
- Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients
- Egg White for Phosphorus Control in Haemodialysis Patients
- EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
- Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
- Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
- Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
- Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan
- Fosrenol Post-marketing Surveillance for Hemodialysis in Japan
- Fosrenol Post-marketing Surveillance in Japan
- Hyperphosphatemia in Children With Chronic Kidney Disease
- Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients
- Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
- Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients
- Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
- Long-term Effect of Lanthanum Carbonate on Bone
- Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease
- Long-term Extension Study of MCI-196
- Long-term Study in Chronic Kidney Disease (Extension From Study 14817)
- Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
- Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
- Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone
- Low-Phosphate Diet and Fibroblast Growth Factor-23 Level
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
- Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
- Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia
- Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)
- Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)
- Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
- Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study
- PA21 Safety and Efficacy in Adult Chinese Subjects
- PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum
- Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate
- Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients
- Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Phosphate Kinetic Modeling
- Phosphate Kinetic Modeling 2
- Phosphate Microvascular Study
- Phosphorus Improvement Pilot Study
- Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients
- Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia
- Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
- Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes
- Safety and Tolerability Study of MCI-196
- Study in Chronic Kidney Disease (CKD) Not on Dialysis
- Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients
- Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
- Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
- Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
- Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy
- Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia
- The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients
- The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
- The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
- The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients
- The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
- The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis
- The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient
- Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules
- To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder
- Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients
- Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
- Velphoro and Impact on the Oral Cavity and Gut Microbiome
- A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
- Administration of Kisspeptin in Patients With Hyperprolactinemia
- Administration of Kisspeptin to Subjects With Reproductive Disorders
- Aripiprazole and Prolactin Study
- Characterization of Macroprolactinemia
- Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
- Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility
- Endometriosis Patients Undergoing Quinagolide Treatment
- Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
- Hyperprolactinemia and Adrenal Steroidogenesis
- Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
- Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
- Pituitary Function and Spontaneous Intracranial Hypotension
- Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
- Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
- Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)
- Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
- The Luveris In Vitro Fertilization Trial
- Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
- A Study in Children With Hyperkalaemia Between Birth and
- A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
- Artificial Intelligence-enable Electrocardiogram for Diagnosis and Outcome in Dyskalemia
- Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium
- Comparison of Dexmedetomidine and Remifentanil Infusion During CABG
- Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
- Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels
- Effect of Licorice and Hydrochlorothiazide on Plasma Potassium
- Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
- Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaCl
- Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients
- Hypomagnesemia Associated With Proton-Pump Inhibitor Use
- Intravenous Fluids in Hospitalised Children
- Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
- Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia
- Patiromer Trial in CKD Stage IIIB to V
- Potassium Supplementation in CKD
- Safety of Continuous Potassium Chloride Infusion in Critical Care
- The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia
- The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis
- Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)
- High-Density Lipoprotein (HDL) Treatment Study
- HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
- Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
- Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
- Mechanisms of Low Levels of Apolipoprotein B
- Prevalence Assessment and Characterization of Psychological Disorders Associated With Hypobetalipoproteinemia
- Short-term Effect of Extended-release Niacin on Endothelial Function.
- Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention
- Tomato Consumption and High Density Lipoprotein-cholesterol